🇺🇸 FDA
Patent

US 9879007

Compounds for treating spinal muscular atrophy

granted A61KA61K31/519A61P

Quick answer

US patent 9879007 (Compounds for treating spinal muscular atrophy) held by PTC THERAPEUTICS, INC. expires Mon Jan 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PTC THERAPEUTICS, INC.
Grant date
Tue Jan 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/519, A61P, A61P21/00, A61P25/00